Skip to content

All best practices

CS-010mixed

Royal Philips (Koninklijke Philips N.V.)

Portfolio transformation from conglomerate to health-technology company

Region
Western Europe, Global
Country
Netherlands, Global
Industry
Medical and Health Technology (Discrete Manufacturing)
Functions
Strategy, Corporate Development & Transformation Office, Finance & FP&A, Risk, Compliance & Internal Audit
Topics
Investment capital is not generating returns; M&A integration or corporate complexity is destroying value; Margins are eroding despite revenue; Regulatory complexity is overwhelming controls
Starting situation
Group of business units
Period
2011–2021
Last verified
31 October 2026

Executive summary

From 2011 to 2021 Royal Philips turned itself from a diversified electronics conglomerate into a health-technology company. It sold its television and lifestyle-entertainment businesses in 2012-2013, ran a cost and operating-model programme called Accelerate!, announced in 2014 that it would split off Lighting, listed Lighting in 2016 and sold the last shares in 2019, and agreed to sell Domestic Appliances in 2021, which its CEO said concluded the major divestments [C01, C02, C04, C06, C07, C08, C09].

Three numbers: a 2011 net loss of EUR 1,291m before the programme [C16]; about EUR 4.4bn of total value from the Domestic Appliances sale, the last major exit [C08]; and a US$1.1bn settlement of US personal-injury claims in 2024 over the Respironics recall in the retained business [C28]. The divestment figures are company-reported; the settlement is company-reported and carries no admission of fault [C28].

KB analysis — the one lesson: Philips executed its announced portfolio separation in stages and on its own terms, but completing a portfolio refocus does not reduce the operational and regulatory risk in the business kept; it concentrates the company's exposure to it.

Outcome: mixed

Documented shortfalls or reversals sit alongside documented gains. For example: an initial failure later recovered, or a strategic goal met while a major adverse event in the same programme was recorded.

Basis of the outcome

Philips carried out the separation it announced in 2014: Lighting was listed in 2016 and fully sold by 2019, and Domestic Appliances was sold in 2021, which Philips said concluded its major divestments. The remaining health-technology company then recorded a recall that the FDA said affected 15 million devices worldwide (Philips expected to remediate up to 5.6 million), a 2024 US consent decree halting new sleep-device sales, and net losses in 2022 and 2023. The KB does not assert that the portfolio strategy caused the recall.

Key figures

PhaseFigureValueWhenVerification
BeforeNet resultEUR −1,291m2011company_reported
BeforeQ4 EBITA margin7.5% (14.1% a year earlier)Q4 2011company_reported
BeforeEmployees (FTE)125,241end 2011company_reported
DuringAccelerate! savings programmeraised to EUR 1.1bn by 2014Sep 2012company_reported
DuringOverhead savings achievedEUR 471m cumulative2012company_reported
During2013 sales of the two future companiesHealthTech EUR 14.8bn; Lighting EUR 8.4bn2013company_reported
DuringLighting IPO25% sold at EUR 20/share; ~EUR 3bn implied valueMay 2016press_reported
DuringFinal Signify sell-down13.8m shares, ~EUR 357mSep 2019company_reported
AfterDomestic Appliances sale~EUR 4.4bn total valueMar 2021company_reported
AfterGroup sales / employeesEUR 17.3bn / ~78,0002020company_reported
AfterRespironics devices in recall15m affected worldwide (FDA); up to 5.6m to be remediated (Philips)2021–2024official_statement
AfterNet resultEUR −1.61bn (2022); EUR −463m (2023)2022–2023press_reported
AfterUS personal-injury settlementUS$1.1bn (EUR 982m provision)Apr 2024company_reported
company_reported
A company statement, press release or investor presentation that no one has independently checked.
press_reported
A journalist's own reporting.
official_statement
A government or ministerial statement. It is official, but political, and is not a finding.

Sources

  1. S01 Philips gives update on its Accelerate! program that continues to make good progress · not stated, Philips (press release, archived on signify.com), 2012-09-11 · accessed 2026-10-31
  2. S02 Electronics giant Philips to split in historic move · Maude Brulard (AFP), IndustryWeek (AFP), 2014-09-23 · accessed 2026-10-31
  3. S03 Philips Lighting spin-off valued at over $3B · not stated, CNBC, 2016-05-27 · accessed 2026-10-31
  4. S04 Royal Philips sells its remaining shares in Signify for total proceeds of approximately EUR 357 million · not stated, Royal Philips, 2019-09-19 · accessed 2026-10-31
  5. S05 Philips to sell its Domestic Appliances business to global investment firm Hillhouse Capital · not stated, Royal Philips, 2021-03-25 · accessed 2026-10-31
  6. S06 Philips stops selling devices in US under FDA consent decree · Nick Paul Taylor, MedTech Dive, 2024-01-29 · accessed 2026-10-31
  7. S20 FDA Activities Related to Recalled Philips Ventilators, BiPAP Machines, and CPAP Machines · not stated, U.S. Food and Drug Administration, 2024-11-20 · accessed 2026-10-31
  8. S21 Communiqué de presse n° 97/15: arrêts du Tribunal dans les affaires des tubes cathodiques (General Court judgments in the cathode-ray-tube cartel cases) · not stated, Court of Justice of the European Union, 2015-09-09 · accessed 2026-10-31
  9. S22 CJEU upholds €1.47bn fines over cathode tube cartels · not stated, Out-Law News (Pinsent Masons), 2017-09-22 · accessed 2026-10-31
  10. S07 Creating two leading companies (presentation on the separation) · Frans van Houten, CEO, Royal Philips, 2014-09-23 · accessed 2026-10-31
  11. S08 Transforming Royal Philips: Seeking Local Relevance While Leveraging Global Scale (MIT CISR Working Paper No. 394) · Martin Mocker, Jeanne W. Ross, Eric van Heck, MIT Sloan Center for Information Systems Research, 2014-02-27 · accessed 2026-10-31
  12. S09 Philips must speed up its operations, says new CEO · not stated, DutchNews.nl, 2011-06-01 · accessed 2026-10-31
  13. S10 Philips picks successor to Kleisterlee · not stated, DutchNews.nl, 2010-07-08 · accessed 2026-10-31
  14. S11 Fourth quarter and annual results 2011 · not stated, Royal Philips (via Mynewsdesk), 2012-01-30 · accessed 2026-10-31
  15. S12 Fourth quarter and annual results 2012 · not stated, Royal Philips, 2013-01 · accessed 2026-10-31
  16. S13 Respironics FAQs (as of 29 January 2024) · not stated, Royal Philips, 2024-01-29 · accessed 2026-10-31
  17. S14 Philips Respironics finalizes consent decree regarding business operations in the US with Department of Justice, FDA · not stated, Pharmaceutical Executive, 2024-04-10 · accessed 2026-10-31
  18. S15 Philips Lighting Unit Sale Blocked Over US Fears · not stated, IndustryWeek (AFP), 2016-01-22 · accessed 2026-10-31
  19. S16 Philips' First-Quarter Results 2024 · not stated, Royal Philips, 2024-04-29 · accessed 2026-10-31
  20. S17 Philips scraps 6,000 jobs in drive to improve profitability · not stated, CNBC, 2023-01-30 · accessed 2026-10-31
  21. S18 Philips' Fourth-Quarter and Annual Results 2021 · not stated, Royal Philips, 2022-01-24 · accessed 2026-10-31
  22. S19 Philips announces CEO succession · not stated, Royal Philips, 2022-08-16 · accessed 2026-10-31

Researched and fact-checked knowledgebase · Knowledgebase built 5 November 2026 · Last verified 31 October 2026

Practices, their evidence grades and case summaries are public. Full case studies are available in AXIOM to subscribers and AXIOM Discover participants.